Plasma concentrations of orexins in children

Annals of Nutrition and Metabolism

Volumn 48, Issue 4, 2004, Pages 215-220

  Tomasik, Przemyslaw J ^a   Spodaryk, Mikolaj ^b   Sztefko, Krystyna ^a  

^a Department of Clinical Biochemistry ^*  (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Body mass index; Energy balance; Orexin A

Indexed keywords

OREXIN; OREXIN A; OREXIN B; PEPTIDE;

ARTICLE; BLOOD LEVEL; BODY MASS; CHILD; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENERGY; FEMALE; HOMEOSTASIS; HUMAN; INFANT; MALE; NEWBORN; PLASMA; PRIORITY JOURNAL; PUBERTY; SEXUAL MATURATION; SLEEP;

ADOLESCENT; AGE FACTORS; BASAL METABOLISM; BODY MASS INDEX; CHILD; CHILD, PRESCHOOL; ENERGY METABOLISM; FEMALE; HOMEOSTASIS; HUMANS; INFANT; INFANT, NEWBORN; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; NEUROPEPTIDES; SEXUAL MATURATION; SLEEP;

ANIMALIA;

EID: 6044225012     PISSN: 02506807     EISSN: None     Source Type: Journal    
DOI: 10.1159/000080453     Document Type: Article

References (19)

1. de Lecea L, Kilduff T, Peyron C, Gao X-B, Foye PE, Danielson PE, Fukuhara C, Battenberg EL, Gautvik VT, Barlett FS, Frankel WN, van den Pol AN, Bloom FE, Gautvik KM, Sutcliffe JG: The hypocretins: Hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci USA 1998;95:322-327.
2. Sakurai T, Amemiya A, Jshii M, Matsuzaki I, Chemelli RM, Tanaka H, Williams SC, Richardson JA, Kozlowski GP, Wilson S, Arch JR, Buckingham RE, Haynes AC, Carr SA, Annan RS, McNulty DE, Liu WS, Terrett JA, Elshourbagy NA, Bergsma DJ, Yanagisawa M: Orexins and orexin receptors: A family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998;92:573-585.
3. Date Y, Ueta Y, Yamashita H, Yamaguchi H, Matsujura S, Kangawa K, Sakurai T, Yanagisawa M, Nakazato M: Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems. Proc Natl Acad Sci USA 1999;96:748-753.
4. Peyron C, Tighe DK, van den Pol AN, de Lecea L, Heller HC, Sutcliffe JG, Kilduff TS: Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 1998;18:9996-10015.
5. van den Pol AN: Hypothalamic hypocretin (orexin): Robust innervation of the spinal cord. J Neurosci 1999;8:3171-3182.
6. Kirchgessner AL, Liu M-T: Orexins synthesis and response in the gut. Neuron 1999;24:941-951.
7. Sutcliffe JG, de Lecea L: The hypocretins: Excitatory neuromedulatory peptides for multiple homeostatic systems, including sleep and feeding. J Neurosci Res 2000;24:429-458.
8. Kopczyńska-Sikorska J, Kurniewicz-Witczakowa R: Rozwo' j fizyczny, wzrastanie i dojrzewanie; in Kopczyńska-Sikorska J, Normy W (eds): Pediatrii. Warsaw, PZWL, 1996, pp 11-65.
9. Ziemlanski S, Bulhak-Jachymczyk B, Budzynska-Topolewska J, Panczenko-Kresowska B, Wartanowicz M: Normy zywienia dla ludnosci w Polsce. Pol J Human Nutr Metab 1994;4:303-338.
10. Matsumura T, Nakayama M, Nomura A, Naito A, Kamahara K, Kadono K, Inoue M, Homma T, Sekizawa K: Age-related changes in plasma orexin-A concentrations. Exp Gerontol 2002;37:1127-1130.
11. Fujiki N, Yoshida Y, Ripley B, Honda K, Mignot E, Nishino S: Changes in CSF hypocretin-I (orexin A) levels in rats across 24 h and in response to food deprivation. NeuroReport 2001;12:993-997.
12. Horvath TL, Diano S, van den Pol AN: Synaptic interaction between hypocretin (orexin) and neuropeptide Y cells in the rodent and primate hypothalamus: A novel circuit implicated in metabolic and endocrine regulations. J Neurosci 1999;19:1072-1087.
13. Nowak KW, Mackowiak P, Switonska MM, Fabis M, Malendowicz LK: Acute orexin effects on insulin secretion in the rat: In vivo and in vitro studies. Life Sci 2000;66:449-454.
14. Adam AJ, Menheere PP, van Dielen FM, Soeters PB, Buurman WA, Greve JW: Decreased plasma orexin-A levels in obese individuals. Int J Obesity 2002;26:274-276.
15. Pu S, Jain MR, Kalra PS, Kalra SP: Orexins, a novel family of hypothalamic neuropeptides, modulate pituitary luteinizing hormone secretion in an ovarian steroid-dependent manner. Regul Pep 1998;78:133-136.
16. Chemelli RM, Willie JT, Sinton CM, Elmquist JK, Scammell T, Lee C, Richardson JA, Williams SC, Xiong Y, Kisanuki Y, Fitch TE, Nakazato M, Hammer RE, Saper CB, Yanagisawa M: Narcolepsy in orexin knockout mice: Molecular genetics of sleep regulation. Cell 1999;98:437-451.
17. Lin L, Faraco J, Kadotani H, Rogers W, Lin X, Qui X, de Jong PJ, Nishino S, Mignot E: The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 1999;98:365-376.
18. Salomon RM, Ripley B, Kennedy JS, Johnson B, Schmidt D, Zeitzer JM, Nishino S, Mignot E: Diurnal variation of cerebrospinal fluid hypocretin-1 (orexin-A) levels in control and depressed subjects. Biol Psychiatry 2003;54:96-104.
19. Kiyashchenko LI, Mileykovskiy BY, Maidment N, Lam HA, Wu M-F, John J, Peever J, Siegel JM: Release of hypocretin (orexin) during waking and sleep states. J Neurosci 2002;22:5282-5286.